fda approved glp-1 drugs for weight loss Medications Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness A big win for Wegovy:

The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: From randomised trials to clinical practice

However, MEDVi advertises a "money-back guarantee." Here's what that means in practice: Patients who do not experience weight loss after five months of consistent treatment may qualify for a refund under the guarantee

[DOI] [PubMed] [Google Scholar] [130].Kanoski SE, Fortin SM, Arnold M, Grill HJ, Hayes MR, Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4, Endocrinology, 152 (2011) 31033112

However, like any medication, there may be potential side effects, and its important to discuss the risks and benefits with your healthcare provider